1. Home
  2. USIO vs LNSR Comparison

USIO vs LNSR Comparison

Compare USIO & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Usio Inc.

USIO

Usio Inc.

HOLD

Current Price

$3.13

Market Cap

81.2M

Sector

Finance

ML Signal

HOLD

Logo LENSAR Inc.

LNSR

LENSAR Inc.

HOLD

Current Price

$6.00

Market Cap

75.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USIO
LNSR
Founded
1998
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medical Electronics
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.2M
75.1M
IPO Year
1999
2005

Fundamental Metrics

Financial Performance
Metric
USIO
LNSR
Price
$3.13
$6.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$5.92
★ $11.33
AVG Volume (30 Days)
★ 172.1K
42.4K
Earning Date
11-11-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
0.01
★ 0.61
Revenue
$28,200,535.00
★ $58,435,000.00
Revenue This Year
$14.57
$4.90
Revenue Next Year
$11.98
$18.71
P/E Ratio
$314.00
★ $9.93
Revenue Growth
★ 12.69
9.24
52 Week Low
$1.03
$4.95
52 Week High
$3.29
$12.94

Technical Indicators

Market Signals
Indicator
USIO
LNSR
Relative Strength Index (RSI) 67.48 36.69
Support Level $2.15 $5.34
Resistance Level N/A $6.20
Average True Range (ATR) 0.18 0.20
MACD 0.03 0.02
Stochastic Oscillator 76.09 30.46

Price Performance

Historical Comparison
USIO
LNSR

About USIO Usio Inc.

Usio Inc is a cloud-based Fintech payment processor. The company serves multiple industry verticals with technology that facilitates payment acceptance and funds disbursement in a single, full-stack ecosystem. It provides payment acceptance through multiple payment methods, including payment facilitation, prepaid card, and electronic billing products and services to businesses, merchants, and consumers. The company's reportable operating segments are Output Solutions and Merchant Services, and these segments.

About LNSR LENSAR Inc.

LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.

Share on Social Networks: